Global Health Data Exchange - Discover the World's Health Data

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

Nav

General Info
Geography 
Germany (DEU)
Time period covered 
01/2004 - 12/2006
Citation
Authors 
Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA, VALUE Trial Group
Journal 
J Hypertens
Volume 
26
Issue 
3
Pages 
403–11
Publication year 
2008
Suggested citation 
Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA, VALUE Trial Group. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens. 2008; 26(3): 403–11.